Related Experiment Videos
Methodological issues in trials of complementary and alternative medicine interventions
Alla Sikorskii1, Gwen Wyatt, David Victorson
1Department of Statistics and Probability, College of Natural Science, Michigan State University, East Lansing, MI, 48824, USA. sikorska@stt.msu.edu
Nursing Research
|November 18, 2009
Summary
Designing rigorous randomized clinical trials for complementary and alternative medicine (CAM) interventions is crucial. This review outlines key methodological considerations for ensuring the safety and efficacy of CAM therapies in cancer care.
Area of Science:
- Oncology
- Integrative Medicine
- Clinical Research Methodology
Background:
- Complementary and alternative medicine (CAM) is frequently used by cancer patients.
- Evidence on the safety and efficacy of CAM therapies is essential for patients and healthcare providers.
- Randomized clinical trials (RCTs) are vital for advancing CAM research and clinical practice.
Purpose of the Study:
- To review critical issues impacting the design of RCTs for CAM interventions.
- To provide guidance for conducting methodologically sound CAM research.
Main Methods:
- Utilized the Consolidated Standards for Reporting Trials (CONSORT) framework.
- Employed a National Cancer Institute-funded reflexology study as a practical example.
- Examined methodological aspects including participants, intervention, objectives, outcomes, sample size, randomization, blinding, and statistical analysis.
Main Results:
- Identified key methodological challenges in designing CAM RCTs.
- Demonstrated that CAM interventions can be effectively tested using established scientific protocols.
Conclusions:
- Implementing appropriate methodological standards in CAM RCTs enhances scientific rigor.
- Results from well-designed CAM trials can inform nursing practice for supportive care.
- Testing CAM interventions can improve patient well-being and provide safe, effective care.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...